STERIS plc has signed a definitive agreement to acquire Cantel Medical Corp in a cash and stock transaction valued at $84.66 per share, representing a total enterprise value of approximately $4.6 billion. The deal is expected to be accretive to adjusted earnings per diluted share in year one.
Cantel Medical Corp. has completed its acquisition of Hu-Friedy, combining it with its existing Crosstex business to form the Cantel Dental division, offering infection prevention and compliance solutions for the dental industry.
Cantel Medical Corp. completed its acquisition of Hu-Friedy Mfg. Co., LLC, a global manufacturer of dental instruments and reprocessing workflow systems. Hu-Friedy will be combined with Cantel's dental division, Crosstex.
Cantel Medical Corp. has reached an agreement to acquire Hu-Friedy Mfg. Co., a 111-year-old manufacturer of dental instruments and reprocessing workflow systems. The acquisition will combine Hu-Friedy with Cantel's dental division, Crosstex.
Cantel Medical Corp. acquired Vista Research Group, a provider of water treatment solutions for the dental industry, for approximately $10.5 million in cash, including a $7 million upfront payment and $3.5 million earnout.
Cantel Medical entered a definitive agreement to purchase BHT Group, a German market leader in automated endoscope reprocessing, for approximately $60.8 million.